{"id":1624,"date":"2022-08-16T10:18:37","date_gmt":"2022-08-16T14:18:37","guid":{"rendered":"https:\/\/www.napra.ca\/national-drug-schedules\/"},"modified":"2026-01-09T10:56:11","modified_gmt":"2026-01-09T15:56:11","slug":"annexes-nationales-de-medicaments","status":"publish","type":"page","link":"https:\/\/www.napra.ca\/fr\/annexes-nationales-de-medicaments\/","title":{"rendered":"Annexes nationales de m\u00e9dicaments"},"content":{"rendered":"\n
\n
\n
\n
\n

Recherchez dans la base de donn\u00e9es des Annexes nationales de m\u00e9dicaments<\/h2>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/a><\/figure>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n

T\u00e9l\u00e9charger les ANM<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

ATTENTION <\/strong>: Tous les r\u00e9sultats de la recherche seront tir\u00e9s du \u00ab National Drug Schedules \u00bb du site Web en anglais.<\/p>\n\n\n\n

Recherche par (en anglais) :<\/p>\n\n\n\n

\n
\n

Nom du m\u00e9dicament* ou mot-cl\u00e9\u00a0<\/p>\n\n\n

<\/div>\n\n\n\n

*Saisir au moins les trois premi\u00e8res lettres du nom du m\u00e9dicament pour de meilleurs r\u00e9sultats.<\/em><\/p>\n\n\n\n

<\/div>\n<\/div>\n\n\n\n
\n

Annexe<\/p>\n\n\n

<\/div>\n<\/div>\n\n\n\n
\n

Note de bas de page<\/p>\n\n\n

<\/div>\n<\/div>\n\n\n\n
<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

Recherche dans le glossaire :<\/p>\n\n\n

<\/div>\n<\/div>\n\n\n\n
<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n
\n
\n

Nom du m\u00e9dicament (en anglais)<\/strong><\/p>\n<\/div>\n\n\n\n

\n

Commentaire (en anglais)<\/strong><\/p>\n<\/div>\n\n\n\n

\n

Annexe<\/strong><\/p>\n<\/div>\n\n\n\n

\n

Date<\/strong><\/p>\n<\/div>\n<\/div>\n\n\n

2,4- Dinitrophenol or its salts or derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
4- Amino-pteroyl aspartic acid or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
4- Aminosalicylic Acid or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
4- Hydroxybutanoic acid (GHB) and any salt thereof<\/a>C<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Nov \/ 20<\/div><\/div><\/div><\/div>
4- Hydroxycoumarin or its derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
Including but not limited to acenocoumarol when sold or recommended as anticoagulants.<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
5- Aminosalicylic acid<\/a>PDL<\/sup><\/div><\/div><\/div>
including but not limited to mesalazine<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Abacavir or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Abatacept<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Abciximab<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Abemaciclib or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Juil \/ 19<\/div><\/div><\/div><\/div>
Abiraterone or its derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
including but not limited to abiraterone acetate<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Abrocitinib or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Oct \/ 22<\/div><\/div><\/div><\/div>
Acalabrutinib or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Oct \/ 19<\/div><\/div><\/div><\/div>
Acamprosate or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Acarbose or its derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Acebutolol or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Acepromazine or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
for human use<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Acetaminophen<\/a>PDL<\/sup><\/div><\/div><\/div>
when recommended for administration by intravenous injection<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Acetaminophen and ibuprofen<\/a><\/sup><\/div><\/div><\/div>
When sold in oral, fixed-dose combinations, in package sizes containing 20,000 mg or less of acetaminophen and 6,000 mg or less of ibuprofen*\n*Note that this listing does not apply to products containing ibuprofen that would meet the criteria to be included on the Prescription Drug list, as these would require a prescription<\/div><\/div>
III<\/div><\/div>
Juil \/ 20<\/div><\/div><\/div><\/div>
Acetaminophen and ibuprofen<\/a><\/sup><\/div><\/div><\/div>
When sold in oral, fixed-dose combinations, in package sizes containing either more than 20,000 mg of acetaminophen or more than 6,000 mg of ibuprofen*\n*Note that this listing does not apply to products containing ibuprofen that would meet the criteria to be included on the Prescription Drug list, as these would require a prescription<\/div><\/div>
II<\/div><\/div>
Juil \/ 20<\/div><\/div><\/div><\/div>
Acetaminophen in sustained release formulations<\/a><\/sup><\/div><\/div><\/div>
up to and including 650 mg per unit, in package sizes containing no more than 50 units<\/div><\/div>
U<\/div><\/div>
Jan \/ 03<\/div><\/div><\/div><\/div>
Acetaminophen in sustained release formulations.<\/a><\/sup><\/div><\/div><\/div>
in strengths of greater than 650 mg per unit or in package sizes of more than 50 units<\/div><\/div>
III<\/div><\/div>
Jan \/ 03<\/div><\/div><\/div><\/div>
Acetaminophen.<\/a><\/sup><\/div><\/div><\/div>
in immediate release tablets, capsules, suppositories or liquid<\/div><\/div>
U<\/div><\/div>
Sep \/ 99<\/div><\/div><\/div><\/div>
Acetanilide<\/a>PDL<\/sup><\/div><\/div><\/div>
for human use<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Acetarsol<\/a><\/sup><\/div><\/div><\/div>
<\/div><\/div>
II<\/div><\/div>
Sep \/ 98<\/div><\/div><\/div><\/div>
Acetazolamide<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Acetohexamide<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Acetylcarbromal<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Acetylcholine Chloride<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Acetylcysteine<\/a><\/sup><\/div><\/div><\/div>
In injectable form<\/div><\/div>
II<\/div><\/div>
Sep \/ 98<\/div><\/div><\/div><\/div>
Acetylsalicylic acid and its salts<\/a><\/sup><\/div><\/div><\/div>
oral preparations containing 80 mg or less per dosage unit and intended for pediatric use or rectal preparations containing 150 mg or less per dosage unit, in package sizes containing no more than 1.92 g of acetylsalicylic acid.<\/div><\/div>
II<\/div><\/div>
F\u00e9v \/ 02<\/div><\/div><\/div><\/div>
Acetylsalicylic acid and its salts.<\/a><\/sup><\/div><\/div><\/div>
in products for oral use in strengths of 325mg and 500mg per dosage unit<\/div><\/div>
U<\/div><\/div>
Oct \/ 00<\/div><\/div><\/div><\/div>
Acetylsalicylic acid and its salts..<\/a><\/sup><\/div><\/div><\/div>
in products intended for oral adult use in strengths of 81 mg per dosage unit and 650 mg or greater per dosage unit, and in rectal preparations containing more than 150 mg per dosage unit<\/div><\/div>
III<\/div><\/div>
Oct \/ 00<\/div><\/div><\/div><\/div>
Acitretin or its salts or derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Aclidinium or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Aconiazide or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Acyclovir or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Adalimumab<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Adapalene or its salts or derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Adefovir or its salts or derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
including but not limited to adefovir dipivoxil<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Adenosine or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
when sold or recommended for administration by intravenous injection<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Adiphene and its salts<\/a><\/sup><\/div><\/div><\/div>
for parenteral use<\/div><\/div>
II<\/div><\/div>
Sep \/ 98<\/div><\/div><\/div><\/div>
Adrenocortical hormones or their salts or derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
for human use including but not limited to: Betamethasone valerate, betamethasone sodium, betamethasone phosphate, betamethasone dipropionate, budesonide, ciclesonide, clobetasone, cortisone, dexamethasone sodium, dexamethasone phosphate, dexamethasone acetate, difluprednate, fludrocortisone acetate, flunisolide, fluticasone propionate, fluticasone furoate, hydrocortisone acetate, hydrocortisone aceponate, hydrocortisone sodium, methylprednisolone acetate, methylprednisolone, methylprednisolone succinate, methylprednisolone sodium, mometasone furoate, prednisolone acetate, prednisolone sodium, prednisolone phosphate, prednisone, triamcinolone acetonide, triamcinolone hexacetonide except: (a) hydrocortisone or hydrocortisone acetate, when sold as a single medicinal ingredient in a concentration that provides 1.0% or less hydrocortisone in preparations for topical use on the skin; or (b) hydrocortisone or hydrocortisone acetate, when sold in combination with any other nonprescription medicinal ingredient that provides 1.0% or less hydrocortisone in preparations for topical use on the skin or (c) clobetasone butyrate when sold in a concentration of 0.05% in cream preparations for topical use on the skin; or (d) triamcinolone acetonide in a nasal spray that delivers 55 microgram (mcg)\/spray for those 12 years of age and older; or, (e) mometasone furoate for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg\/spray for those 12 years of age and older; or (f) fluticasone propionate for the treatment of allergic rhinitis in a nasal spray that delivers 50 microgram\/spray for those 18 years of age and older.<\/div><\/div>
I<\/div><\/div>
Ao\u00fbt \/ 16<\/div><\/div><\/div><\/div>
Afatinib or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Aflibercept<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Afoxolaner<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Ao\u00fbt \/ 14<\/div><\/div><\/div><\/div>
Agalsidase Alfa<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Avr \/ 07<\/div><\/div><\/div><\/div>
Agalsidase Beta<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 14<\/div><\/div><\/div><\/div>
Albiglutide<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Ao\u00fbt \/ 15<\/div><\/div><\/div><\/div>
Aldesleukin<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Alectinib or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Nov \/ 16<\/div><\/div><\/div><\/div>
Alefacept<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Alemtuzumab<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Alendronic acid or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Alfacalcidol<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Alfuzosin or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Alglucosidase alfa<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Alirocumab<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Ao\u00fbt \/ 16<\/div><\/div><\/div><\/div>
Aliskiren or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Alitretinoin or its salts or derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Alkyl nitrites<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Allergy serums and extracts<\/a><\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Sep \/ 99<\/div><\/div><\/div><\/div>
Allethrins<\/a><\/sup><\/div><\/div><\/div>
<\/div><\/div>
II<\/div><\/div>
Sep \/ 98<\/div><\/div><\/div><\/div>
Allopurinol<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Allylisopropylacetylurea<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Almotriptan or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Alogliptin or its salts or its derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Alpelisib or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Juil \/ 20<\/div><\/div><\/div><\/div>
Alpha-chloralose<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Alpha-hydroxy acids<\/a>PDL<\/sup><\/div><\/div><\/div>
including but not limited to citric acid, glycolic acid, lactic acid, malic acid, mandelic acid, ammonium glycolate, glycolic acid + ammonium glycolate, alpha-hydroxyethanoic acid + ammonium alpha-hydroxyethanoate, alpha-hydroxyoctanoic acid, alpha-hydroxycaprylic acid, hydroxycaprylic acid, mixed fruit acid, triple fruit acid, tri-alpha hydroxy fruit acids, alpha hydroxy and botanical complex, l-alpha hydroxy acid, glycomer in cross-linked fatty acids alpha nutrium, when sold in topical formulations containing alpha hydroxy acids alone or in combination at concentrations of greater than 30% and\/or with a pH lower than 3.0, except when sold to be applied to warts, corns or calluses<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 14<\/div><\/div><\/div><\/div>
Alpha1- proteinase inhibitor (human)<\/a><\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Jan \/ 06<\/div><\/div><\/div><\/div>
Alphadolone or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Alphaxalone<\/a>PDL<\/sup><\/div><\/div><\/div>
including but not limited to alfaxalone, alphaxolone<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Alteplase or its salts or derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
including but not limited to tenecteplase<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Altrenogest<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Altretamine<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Alverine and its salts<\/a><\/sup><\/div><\/div><\/div>
in injectable form<\/div><\/div>
I<\/div><\/div>
Sep \/ 98<\/div><\/div><\/div><\/div>
Amantadine or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Ambenonium Chloride<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Ambrisentan<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Amidones, their intermediates, salts, derivatives and salts of intermediates and derivatives<\/a>N<\/sup><\/div><\/div><\/div>
Including: Dimethylaminodiphenylbutanonitrile; Dipipanone; Isomethadone; Methadone; Normethadone; Norpipanone; Phenadoxone<\/div><\/div>
I<\/div><\/div>
Juin \/ 02<\/div><\/div><\/div><\/div>
Amifampridine or its salts or derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Sep \/ 20<\/div><\/div><\/div><\/div>
Amifostine or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Amikacin or its salts or derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
PDL, including but not limited to amikacin sulfate<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Amiloride or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Amineptine and any salt thereof<\/a>C<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Nov \/ 20<\/div><\/div><\/div><\/div>
Amino Acid solutions<\/a><\/sup><\/div><\/div><\/div>
in injectable form<\/div><\/div>
I<\/div><\/div>
Sep \/ 99<\/div><\/div><\/div><\/div>
Aminocaproic acid<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Aminoglutethimide<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Aminolevulinic acid or its salts or derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Aminophylline<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Aminopromazine [proquamezine] and its salts<\/a><\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Sep \/ 98<\/div><\/div><\/div><\/div>
Aminopterin or its salts or derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Aminopyrine or its derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
for human use<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Aminorex, its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues<\/a>C<\/sup><\/div><\/div><\/div>
Including 4-Methylaminorex and 4,4'-Dimethylaminorex.<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 17<\/div><\/div><\/div><\/div>
Amiodarone or its salts or derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
including but not limited to dronedarone<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Amitraz<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Amitriptyline or its salts<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div>
Amivantamab<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
Juin \/ 22<\/div><\/div><\/div><\/div>
Amlexanox or its salts or derivatives<\/a>PDL<\/sup><\/div><\/div><\/div>
<\/div><\/div>
I<\/div><\/div>
D\u00e9c \/ 13<\/div><\/div><\/div><\/div><\/div>\n